Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes ...
Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...
"CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline"DelveInsight's,“CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2025,” report provides comprehensive insights ...
Munir is an advisor or consultant for Alexion, AstraZeneca, BeiGene, Janssen, Lilly, MorphoSys, Roche, Sobi, and Sunesis; has received research grants from AbbVie, Janssen, and Pharmacyclics; and ...
Wendtner has served on advisory boards for AbbVie, Amgen, Astrazeneca, BeOne Medicines, BIONTech, Cllag-Janssen, F. Hoffmann-La Roche, Genentech, Gilead, GSK ...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adult patients living in the western hemisphere. The annual incidence of CLL is 4.2/100 000 people, with median (interquartile range ...
This report focuses on multiple aspects of predictive policing in the UK, including the systems themselves, the policing outcomes or decisions they influence, and the impact on individuals, groups and ...
David is comprehensively experienced in many facets of financial and legal research and publishing. As an Investopedia fact checker since 2020, he has validated over 1,100 articles on a wide range of ...
This is a retrospective observational study using Optum Clinformatics Data Mart of adult patients with CLL/small lymphocytic lymphoma who received 2L venetoclax- or BTKi-based regimens (January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results